The Association of Genetic Polymorphisms With Statin-Induced Myopathy.

NCT00549029 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2007-10-25

No results posted yet for this study

Summary

To observe not only the distribution of single nucleotide polymorphism in genes related with pharmacodynamic and pharmacokinetics alteration of statins but also to analyze the correlation between these SNPs and the incidence of statins-induced myopathy.

Conditions

  • Rhabdomyolysis
  • Myopathy

Interventions

GENETIC

DNA

withdraw 5\~10mL blood from vein only once during the whole design

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Yen-Hui Chen, PhD · National Taiwan Univesity College of Medicine

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Completion
2008-01-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00549029 on ClinicalTrials.gov